Language
First in-human HIV vaccine to induce virus-specific neutralizing antibodies | Fred Hutchinson Cancer Center

Blog

HomeHome / Blog / First in-human HIV vaccine to induce virus-specific neutralizing antibodies | Fred Hutchinson Cancer Center
search

May 20, 2023

Autophagy

Jun 09, 2023

Super

Oct 29, 2023

Statement on the antigen composition of COVID

Jul 18, 2023

Postoperative serum interleukin

Jun 11, 2023

Recombinant Protein Market is Projected To Reach A Revised Size of USD 2,320.21 Million By 2029, Growing At A CAGR of 13.02%

Send your inquiry
SUBMIT

Oct 19, 2024

First in-human HIV vaccine to induce virus-specific neutralizing antibodies | Fred Hutchinson Cancer Center

Science spotlight writer Annabel Olson is a postdoctoral research fellow in the Nabet lab at Fred Hutchinson Cancer Center. Her research focuses on studying the mechanisms that drive cancer

Science spotlight writer Annabel Olson is a postdoctoral research fellow in the Nabet lab at Fred Hutchinson Cancer Center. Her research focuses on studying the mechanisms that drive cancer development for both genetic and virus-associated cancers. A key tool in her research is the use of targeted protein degradation to dissect dysregulated signaling pathways in cancer and to double as a relevant pre-clinical therapeutic platform.